ADHANSIA XR
- Product NDC
- 72912-545
- 11-digit product format
- 729120545
- Labeler code
- 72912
- Product ID
- 72912-545_d5202e47-4f6c-423a-8f94-a8a5402da896
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methylphenidate hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Adlon Therapeutics L.P.
- Application
- NDA212038
- Marketing category
- NDA
- Marketing start
- 2019-07-01
- Marketing end
- 2023-11-01
- Substance
- METHYLPHENIDATE HYDROCHLORIDE
- Active strength
- 45 mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72912-545-30 | 72912054530 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72912-545-30) | 2019-07-01 | 0000-00-00 | No | No | Current |